U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C13H9Cl3N2O
Molecular Weight 315.582
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TRICLOCARBAN

SMILES

ClC1=CC=C(NC(=O)NC2=CC(Cl)=C(Cl)C=C2)C=C1

InChI

InChIKey=ICUTUKXCWQYESQ-UHFFFAOYSA-N
InChI=1S/C13H9Cl3N2O/c14-8-1-3-9(4-2-8)17-13(19)18-10-5-6-11(15)12(16)7-10/h1-7H,(H2,17,18,19)

HIDE SMILES / InChI

Molecular Formula C13H9Cl3N2O
Molecular Weight 315.582
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created using several sources including: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm517478.htm; http://www.fda.gov/downloads/aboutfda/reportsmanualsforms/reports/economicanalyses/ucm519798.pdf; https://www.ncbi.nlm.nih.gov/pubmed/22626523; https://www.ncbi.nlm.nih.gov/pubmed/21131331; http://www.ncbi.nlm.nih.gov/pubmed/?term=12534815

Triclocarban is a triclosan analogue with an antibmicrobial property. It has been used in a wide range of personal cleansing products including deodorant and bar soaps, deodorants, detergents, cleansing lotions, and wipes. In US triclocarban was approved for marketing of over-the-counter (OTC) consumer antiseptic wash products. But on September 2, 2016 U.S. Food and Drug Administration banned containing triclocarban and triclosan consumer antiseptic wash products from further marketing in USA because of a potential damage to human health, resulting from extended exposure to antiseptic active ingredients on a regular bases. However the new rule does not not affect consumer hand “sanitizers” or wipes, or antibacterial products used in health care settings. Triclocarban is a limited spectrum antibacterial agent effective in vitro against some strains of staphylococcus, streptococcus, and enterococcus bacteria. The minimum inhibitory concentration has been found to range from 0.5 to 8 mg/L for these various strains. Triclocarban can act by non-specific membrane-destabilizing mechanism; also was suggested, that similar to triclosan, Triclocarban exerts its effect by inhibiting the activity of enoyl-(acyl-carrier protein) (ACP) reductase, widely distributed in bacteria, fungi and plants. As a result, this agent interrupts cell membrane synthesis and leads to bacterial growth inhibition.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
Dial® soap

Approved Use

Antibacterial Soap used to protect skin from bacterial infections
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
8.6 h
103 μg single, intravenous
dose: 103 μg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
TRICLOCARBAN blood
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
Doses

Doses

DosePopulationAdverse events​
9 % 1 times / day multiple, topical
Highest studied dose
Dose: 9 %, 1 times / day
Route: topical
Route: multiple
Dose: 9 %, 1 times / day
Sources:
healthy, 21 to 65 years old
Other AEs: Skin irritation...
AEs

AEs

AESignificanceDosePopulation
Skin irritation grade 1
9 % 1 times / day multiple, topical
Highest studied dose
Dose: 9 %, 1 times / day
Route: topical
Route: multiple
Dose: 9 %, 1 times / day
Sources:
healthy, 21 to 65 years old
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG

OverviewOther

Other InhibitorOther SubstrateOther Inducer






Drug as perpetrator​Drug as victim
PubMed

PubMed

TitleDatePubMed
Effects of triclocarban on the transcription of estrogen, androgen and aryl hydrocarbon receptor responsive genes in human breast cancer cells.
2013-08
Triclocarban mediates induction of xenobiotic metabolism through activation of the constitutive androstane receptor and the estrogen receptor alpha.
2012
Effects of bisphenol A and triclocarban on brain-specific expression of aromatase in early zebrafish embryos.
2011-10-25
Inhibition of soluble epoxide hydrolase contributes to the anti-inflammatory effect of antimicrobial triclocarban in a murine model.
2011-09-01
Electrochemistry-mass spectrometry unveils the formation of reactive triclocarban metabolites.
2010-12
Occurrence and loss over three years of 72 pharmaceuticals and personal care products from biosolids-soil mixtures in outdoor mesocosms.
2010-12
Identification of wastewater bacteria involved in the degradation of triclocarban and its non-chlorinated congener.
2010-11-15
Some flame retardants and the antimicrobials triclosan and triclocarban enhance the androgenic activity in vitro.
2010-11
Personal care products and endocrine disruption: A critical review of the literature.
2010-11
Analysis of triclosan and triclocarban in soil and biosolids using molecularly imprinted solid phase extraction coupled with HPLC-UV.
2010-10-07
Aquatic hazard assessment for pharmaceuticals, personal care products, and endocrine-disrupting compounds from biosolids-amended land.
2010-10
Rapid resolution liquid chromatography-tandem mass spectrometry method for the determination of endocrine disrupting chemicals (EDCs), pharmaceuticals and personal care products (PPCPs) in wastewater irrigated soils.
2010-10
Transformation of triclosan and triclocarban in soils and biosolids-applied soils.
2010-09-14
Computational thermochemistry of six ureas, imidazolidin-2-one, N,N'-trimethyleneurea, benzimidazolinone, parabanic acid, barbital (5,5'-diethylbarbituric acid), and 3,4,4'-trichlorocarbanilide, with an extension to related compounds.
2010-09-02
Use of chemical mixtures to differentiate mechanisms of endocrine action in a small fish model.
2010-09-01
Retention-release characteristics of triclocarban and triclosan in biosolids, soils, and biosolids-amended soils.
2010-09
Triclocarban and triclosan biodegradation at field concentrations and the resulting leaching potentials in three agricultural soils.
2010-09
Uptake of pharmaceutical and personal care products by soybean plants from soils applied with biosolids and irrigated with contaminated water.
2010-08-15
Stir-bar-sorptive extraction and ultra-high-performance liquid chromatography-tandem mass spectrometry for simultaneous analysis of UV filters and antimicrobial agents in water samples.
2010-08
Self-reported chemicals exposure, beliefs about disease causation, and risk of breast cancer in the Cape Cod Breast Cancer and Environment Study: a case-control study.
2010-07-20
Occurrence and risks of triclosan and triclocarban in the Pearl River system, South China: from source to the receiving environment.
2010-07-15
Measured physicochemical characteristics and biosolids-borne concentrations of the antimicrobial Triclocarban (TCC).
2010-06-01
Fate of 14C-triclocarban in biosolids-amended soils.
2010-06-01
Characterization of the androgen-sensitive MDA-kb2 cell line for assessing complex environmental mixtures.
2010-06
Temperature-controlled ionic liquid dispersive liquid-phase microextraction for the sensitive determination of triclosan and triclocarban in environmental water samples prior to HPLC-ESI-MS/MS.
2010-06
Quantitative gene monitoring of microbial tetracycline resistance using magnetic luminescent nanoparticles.
2010-06
Trace determination of triclosan and triclocarban in environmental water samples with ionic liquid dispersive liquid-phase microextraction prior to HPLC-ESI-MS-MS.
2010-06
The antimicrobial triclocarban stimulates embryo production in the freshwater mudsnail Potamopyrgus antipodarum.
2010-04
Quantitative determination of triclocarban in wastewater effluent by stir bar sorptive extraction and liquid desorption-liquid chromatography-tandem mass spectrometry.
2010-03-12
Triclocarban, triclosan, polybrominated diphenyl ethers, and 4-nonylphenol in biosolids and in soil receiving 33-year biosolids application.
2010-03
Mass loadings of triclosan and triclocarbon from four wastewater treatment plants to three rivers and landfill in Savannah, Georgia, USA.
2010-02
Pharmaceuticals and personal care products in archived U.S. biosolids from the 2001 EPA National Sewage Sludge Survey.
2010-01
Fate of triclocarban during soil aquifer treatment: soil column studies.
2010
Toxicology in the fast lane: application of high-throughput bioassays to detect modulation of key enzymes and receptors.
2009-12
Fate of organohalogens in US wastewater treatment plants and estimated chemical releases to soils nationwide from biosolids recycling.
2009-12
Bioaccumulation of triclocarban in Lumbriculus variegatus.
2009-12
On-line solid-phase extraction of large-volume injections coupled to liquid chromatography-tandem mass spectrometry for the quantitation and confirmation of 14 selected trace organic contaminants in drinking and surface water.
2009-11-27
Impact of biosolids on the persistence and dissipation pathways of triclosan and triclocarban in an agricultural soil.
2009-11-15
Effect of triclosan and triclocarban biocides on biodegradation of estrogens in soils.
2009-11
Ultra-high-performance liquid chromatography-tandem mass spectrometry for determining the presence of eleven personal care products in surface and wastewaters.
2009-10-16
Runoff of pharmaceuticals and personal care products following application of dewatered municipal biosolids to an agricultural field.
2009-08-01
Pharmaceutical and personal care products in tile drainage following surface spreading and injection of dewatered municipal biosolids to an agricultural field.
2009-07-01
Adsorption and degradation of triclosan and triclocarban in soils and biosolids-amended soils.
2009-06-10
Simultaneous determination of parabens, triclosan and triclocarban in water by liquid chromatography/electrospray ionisation tandem mass spectrometry.
2009-06
Comparative microscale analysis of the effects of triclosan and triclocarban on the structure and function of river biofilm communities.
2009-05-01
Detection of the antimicrobials triclocarban and triclosan in agricultural soils following land application of municipal biosolids.
2009-05
Determination of triclosan, triclocarban and methyl-triclosan in aqueous samples by dispersive liquid-liquid microextraction combined with rapid liquid chromatography.
2009-04-10
Simultaneous determination of 21 preservatives in cosmetics by ultra performance liquid chromatography.
2008-10
Meta-analysis of mass balances examining chemical fate during wastewater treatment.
2008-09-01
In vitro biologic activities of the antimicrobials triclocarban, its analogs, and triclosan in bioassay screens: receptor-based bioassay screens.
2008-09
Patents

Sample Use Guides

Use Dial® soap containing 0.30% triclocarban for hand and body wash
Route of Administration: Other
To study effects of antimicrobial agents on the growth of P. aeruginosa at 37°C triclocarban at concentrations of 0 - 5 ug/ml were used
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:55:28 GMT 2025
Edited
by admin
on Mon Mar 31 17:55:28 GMT 2025
Record UNII
BGG1Y1ED0Y
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-72005
Preferred Name English
TRICLOCARBAN
HSDB   INCI   INN   MART.   MI   USAN   USP-RS   WHO-DD  
INCI   INN   USAN  
Official Name English
UREA, N-(4-CHLOROPHENYL)-N'-(3,4-DICHLOROPHENYL)-
Systematic Name English
1-(4-CHLOROPHENYL)-3-(3,4-DICHLOROPHENYL)UREA
Systematic Name English
TRICLOCARBAN [MI]
Common Name English
TRICLOCARBAN [USP-RS]
Common Name English
TRICLOCARBAN [HSDB]
Common Name English
TRICLOCARBAN [USP MONOGRAPH]
Common Name English
Triclocarban [WHO-DD]
Common Name English
triclocarban [INN]
Common Name English
3,4,4'-TRICHLOROCARBANILIDE
Common Name English
TRICLOCARBAN [USAN]
Common Name English
TRICLOCARBAN [MART.]
Common Name English
Classification Tree Code System Code
EPA PESTICIDE CODE 27901
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
NCI_THESAURUS C28394
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
Code System Code Type Description
DRUG CENTRAL
3630
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY
MERCK INDEX
m11089
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY Merck Index
INN
2017
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY
NCI_THESAURUS
C47770
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY
ECHA (EC/EINECS)
202-924-1
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY
RXCUI
38609
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY RxNorm
DAILYMED
BGG1Y1ED0Y
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY
PUBCHEM
7547
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY
WIKIPEDIA
TRICLOCARBAN
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY
NSC
72005
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY
HSDB
5009
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY
RS_ITEM_NUM
1681800
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY
CHEBI
48347
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY
MESH
C009540
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY
FDA UNII
BGG1Y1ED0Y
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY
DRUG BANK
DB11155
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY
SMS_ID
100000077518
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY
ChEMBL
CHEMBL1076347
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY
CAS
101-20-2
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY
EVMPD
SUB11271MIG
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY
EPA CompTox
DTXSID4026214
Created by admin on Mon Mar 31 17:55:28 GMT 2025 , Edited by admin on Mon Mar 31 17:55:28 GMT 2025
PRIMARY
Related Record Type Details
METABOLIC ENZYME -> SUBSTRATE
MAJOR
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
MAJOR
METABOLIC ENZYME -> SUBSTRATE
MAJOR
Related Record Type Details
METABOLITE -> PARENT
METABOLITE -> PARENT
METABOLITE -> PARENT
METABOLITE -> PARENT
IN VITRO
METABOLITE -> PARENT
METABOLITE -> PARENT
METABOLITE -> PARENT
URINE
Related Record Type Details
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Tmax PHARMACOKINETIC ORAL ADMINISTRATION